Home/ Supplements/ Niacin/ No-Flush Niacin

No-Flush Niacin

product on market Capsule Allergy Research Group Safety: 60/100
60/100

Review before taking

  • Niacin: 430mg is 12.3× the Tolerable Upper Intake Level (35mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Niacin is used to support cholesterol levels and metabolic health, though evidence for this specific no-flush formulation is limited. Due to a safety score of 60, potential concerns regarding liver enzyme elevation or glucose intolerance may exist. Users should monitor for adverse reactions associated with high-dose niacin supplementation.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 430mg is 12.3× the Tolerable Upper Intake Level (35mg)

AI-generated · Qwen 3.6 · grounded in 2 sources · methodology

This product received a low safety score because it contains 430mg of Niacin, which is over 12 times the recommended upper limit for daily intake.

Label

Product Label

Label for No-Flush Niacin
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
75
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

430 mg (2688% DV)
Exceeds UL by 12.3× (UL: 35 mg) 196 studies (A:5, B:63)

Other Ingredients

Hydroxypropyl Methylcellulose Microcrystalline Cellulose L-Leucine
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use As a dietary supplement, 1 capsule two or three times daily with meals, or as directed by a healthcare practitioner.

Warnings & Precautions

Do not take large amounts of Niacin (greater than 1.5 grams per day) without first consulting a healthcare practitioner.

Formulation Notes

Provides inositol hexanicotinate. Taken orally, the niacin releases slowly, thereby minimizing the likelihood of "niacin flush". Though chemically linked to inositol, the niacin in this formulation is highly bio-available.

Inositol Hexanicotinate

Hypoallergenic

Additional Information

Keep in a cool, dry place, tightly capped.

Metadata

Product Details

UPC / SKU7 13947 70370 4
DSLD Entry Date2020-08-23
Product TypeVitamin
FormCapsule
DSLD ID233222
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.